These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7371698)

  • 1. Inhibition by idrocilamide of the disposition of caffeine.
    Brazier JL; Descotes J; Lery N; Ollagnier M; Evreux JC
    Eur J Clin Pharmacol; 1980 Jan; 17(1):37-43. PubMed ID: 7371698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An animal model for the detection of drug-induced inhibition of caffeine metabolism.
    Tarrús E; García I; Roberts DJ; Segura J
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):311-6. PubMed ID: 3613760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of idrocilamide on the metabolism of theophylline].
    Lacroix C; Nouveau J; Hubscher P; Tardif D; Ray M; Goulle JP
    Rev Pneumol Clin; 1986; 42(3):164-6. PubMed ID: 3775181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two sites of action for LCB29 (idrocilamide) in depressing mechanical tension of rat soleus muscle fibers?
    Mouzou A; Bouron A; Guillemain J; Guerrier D; Raymond G
    Can J Physiol Pharmacol; 1993 Dec; 71(12):889-95. PubMed ID: 8180884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue and systemic diffusion of idrocilamide after cutaneous administration].
    Bannwarth B; Le Huec JC; Vinçon G; Labat L; Demotes-Mainard F; Rivaille F; Le Rebeller A
    Rev Rhum Ed Fr; 1993 Dec; 60(12):932-6. PubMed ID: 8012322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct depressant effect of LCB29 (idrocilamide) on mechanical tension of rat soleus muscle fibers.
    Bouron A; Rivet M; Nasri-Sebdani M; Guillemain J; Durbin P; Guerrier D; Raymond G
    Can J Physiol Pharmacol; 1990 Dec; 68(12):1503-9. PubMed ID: 2085796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of quinolones on caffeine disposition.
    Carbó M; Segura J; De la Torre R; Badenas JM; Camí J
    Clin Pharmacol Ther; 1989 Mar; 45(3):234-40. PubMed ID: 2920498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine metabolism in the newborn.
    Aldridge A; Aranda JV; Neims AH
    Clin Pharmacol Ther; 1979 Apr; 25(4):447-53. PubMed ID: 428190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of caffeine in healthy volunteers treated with furafylline.
    Tarrus E; Cami J; Roberts DJ; Spickett RG; Celdran E; Segura J
    Br J Clin Pharmacol; 1987 Jan; 23(1):9-18. PubMed ID: 3814465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine disposition after oral doses.
    Bonati M; Latini R; Galletti F; Young JF; Tognoni G; Garattini S
    Clin Pharmacol Ther; 1982 Jul; 32(1):98-106. PubMed ID: 7083737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of allopurinol on caffeine disposition in man.
    Grant DM; Tang BK; Campbell ME; Kalow W
    Br J Clin Pharmacol; 1986 Apr; 21(4):454-8. PubMed ID: 3754760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of caffeine on the oral absorption and disposition of quinidine.
    Zeller FP; Ueda CT; Wulf BG; Meyers DG
    Clin Pharm; 1984; 3(1):72-5. PubMed ID: 6697677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of caffeine and its metabolites in man.
    Tang-Liu DD; Williams RL; Riegelman S
    J Pharmacol Exp Ther; 1983 Jan; 224(1):180-5. PubMed ID: 6848742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine.
    Callahan MM; Robertson RS; Branfman AR; McComish MF; Yesair DW
    Drug Metab Dispos; 1983; 11(3):211-7. PubMed ID: 6135578
    [No Abstract]   [Full Text] [Related]  

  • 15. The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects.
    Bruce M; Scott N; Lader M; Marks V
    Br J Clin Pharmacol; 1986 Jul; 22(1):81-7. PubMed ID: 3741730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of caffeine on aspirin pharmacokinetics.
    Yoovathaworn KC; Sriwatanakul K; Thithapandha A
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):71-6. PubMed ID: 3720797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics.
    Beach CA; Mays DC; Guiler RC; Jacober CH; Gerber N
    Clin Pharmacol Ther; 1986 Mar; 39(3):265-70. PubMed ID: 3948467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical double-blind study with idrocilamide ointment in the treatment of acute lumbago].
    Stehman M; Lehert P
    Acta Belg Med Phys; 1990; 13(1):29-32. PubMed ID: 2140002
    [No Abstract]   [Full Text] [Related]  

  • 19. [Letter: Unusual neuropsychic effects due to idrocilamide].
    Lery N; Evreux JC; Schwam E; Laisne H
    Nouv Presse Med; 1976 Feb; 5(9):583-4. PubMed ID: 1264724
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites.
    Kadlubar FF; Talaska G; Butler MA; Teitel CH; Massengill JP; Lang NP
    Prog Clin Biol Res; 1990; 340B():107-14. PubMed ID: 2392442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.